Skip to content

A prospective cohort study on the optimization of early diagnosis and management strategies for pediatric severe drug eruption SJS/TEN

A prospective cohort study on the optimization of early diagnosis and management strategies for pediatric severe drug eruption SJS/TEN

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500101250
Enrollment
Unknown
Registered
2025-04-22
Start date
2025-05-06
Completion date
Unknown
Last updated
2025-04-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stevens-Johnson syndrome

Interventions

Traditional treatment group:High-dose hormone +IVIG group:High-dose hormone +IVIG
Biological agent treatment group:High-dose hormones +TNF-a inhibitors:High-dose hormones +TNF-a inhibitors

Sponsors

Children's Hospital of Chongqing Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
No minimum to 18 Years

Inclusion criteria

Inclusion criteria: 1.Conforming to the diagnostic criteria of "Clinical Diagnosis and Treatment Guidelines. Dermatology and Venereal Diseases Volume" (compiled by the Chinese Medical Association, People's Medical Publishing House, 2006); 2.Clear medication history; 3.Certain incubation period; 4.The onset is sudden and the progression is rapid. 5.The rash presents as generalized and symmetrically distributed erythema accompanied by epidermal exfoliation, with Nich's sign (+), and mucosal damage. 6.With or without systemic symptoms such as fever; 7.Age: 0-18 years old. Sign the informed consent form.

Exclusion criteria

Exclusion criteria: 1.Children diagnosed with other severe drug eruptions or Staphylococcal scald skin syndrome.

Design outcomes

Primary

MeasureTime frame
Skin regeneration time;The time for body temperature to return to normal;

Secondary

MeasureTime frame
Serum biological markers;Healing time of the skin and mucous membranes;

Countries

China

Contacts

Public ContactXiangjuan

Children's Hospital of Chongqing Medical University

xiangjuan1102@163.com+86 23 63638830

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026